Emergent BioSolutions Inc. — Director's Dealing 2023

Mar 2, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2023-02-28

Reporting Person: Williams Paul Anthony (SVP, Products Business)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-28	Common Stock	F	371	$12.38	Disposed	8916	Direct

Footnotes

F1: Represents shares of common stock withheld to pay taxes.